Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 572.0800 ↓ -0.24%
[as on 6 March, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option and its peers as on 6 March, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 0.45% -0.24% -0.84% 3% -0.65% 10% 24.91% 16.61% 20.13% 15.04%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.88% -0.48% -2.33% -2.98% -7.15% 0.58% 13.01% 15.94% 15.17% 15.96%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.68% -1.18% -3.5% -3.99% -6.28% 8.33% 13.66% 11.75% 13.69% 13.62%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 2.01% -0.09% -0.62% 4.31% 0.05% 8.52% 27.17% 18.41% 21.54% 13.29%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -4.22% -0.61% -3.2% -3.17% -3.24% 8.99% 20.54% 19.96% 19.54% 17.48%
SBI PSU Fund - DIRECT PLAN - GROWTH 6.09% -0.46% -2.93% 1.91% 8.44% 29.55% 33.66% 28.09% 21.61% 17.17%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-9.42%8.09%4.71%2.97%68.53%23.84%-9.16%41.33%35.46%-2.94%

Discrete returns (monthly)

MonthMay 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026
Returns1.43%3%2.66%-1.41%-2.52%2.24%0.9%-1.24%-4.66%5.31%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns13.06%-0.48%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.67% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.33%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.67%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.07%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.26%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.29%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.97%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.62%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.42%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.32%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.87%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.83%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.81%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.59%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.39%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.32%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.29%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.16%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.14%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.10%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.01%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.99%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.95%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.48%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.35%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.32%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.24%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services1.23%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.00%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.90%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.84%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology0.74%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.72%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.61%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.19%
Portfolio data is as on date 31 October, 2025

NAV history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV
6 March, 2026572.0800
5 March, 2026573.4843
4 March, 2026566.7355
2 March, 2026574.4547
27 February, 2026576.9248
26 February, 2026582.0874
25 February, 2026577.5420
24 February, 2026569.7749
23 February, 2026571.1316
20 February, 2026566.4993
19 February, 2026566.6474
18 February, 2026569.7016
17 February, 2026569.6540
16 February, 2026566.7947
13 February, 2026562.6333
12 February, 2026567.1247
11 February, 2026570.6492
10 February, 2026565.0555
9 February, 2026562.4167
6 February, 2026555.4307
5 February, 2026556.3385
4 February, 2026555.8449
3 February, 2026557.7097
2 February, 2026542.9962
30 January, 2026545.5001
29 January, 2026539.2707
28 January, 2026545.2017
27 January, 2026544.1395
23 January, 2026543.9098
22 January, 2026550.6493

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 572.0800 as on 6 March, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 0.45% as on 6 March, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 10% as on 6 March, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 24.91% as on 6 March, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 16.61% as on 6 March, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 16.61% as on 6 March, 2026.